Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.

Cowen and Company 38th Annual Health Care Conference Monday, March 12, 2018 at 12:00 p.m. ET in Boston, MA

Barclays Global Healthcare ConferenceWednesday, March 14, 2018 at 2:35 p.m. ET in Miami, FL   A webcast of each presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com.  A replay of each presentation will be posted on the Momenta website approximately one hour after the event.

About MomentaMomenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

Contact: Sarah CarmodyMomenta Pharmaceuticals1-617-395-5189[email protected]

Source: Momenta Pharmaceuticals, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BNB News: BNB Nears $669, LINK Hits 7-Month High – But the Next Crypto to Explode May Be a New Presale 
• 2026’s Top Window Covering Trends, and the Sister-Owned Store Carrying Them All
• Bitcoin Price Prediction: BTC Eyes $100K Comeback as AlphaPepe Buyers Countdown to the 4th CEX Reveal